Pharmacology of antiandrogens.
Principally, antiandrogens affect all androgen-dependent organs and functions as for instance accessory sexual glands, spermatogenesis, skin and skin appendages, libido and potency, male sexual differentiation, longitudinal bone growth and bone maturation. Pharmacologically, it is important to distinguish between the steroidal antiandrogens of the cyproterone acetate type and the nonsteroidal pure antiandrogens (flutamide, anandrone). For the clinical use of cyproterone acetate and similar antiandrogens in both men and women the three main properties are important: Cyproterone acetate is antiandrogenic, it is a quite potent progestogen and it is antigonadotrophic. Based on pharmacological and biochemical backgrounds cyproterone acetate is used in the following indications: Androgen mediated disorders of the skin such as acne, seborrhoea, hirsutism, alopecia, advanced prostatic carcinoma, precocious puberty and male hypersexuality. In order to avoid undesired systemic side effects local application of antiandrogens, e.g. of cyproterone acetate, has been tried several times. All these attempts have failed probably because insufficient concentration of the antiandrogen at the pilo sebaceous unit. 17 alpha-propylmesterolone is active when given topically (hamster ear model) and has no systemic antiandrogenic effects. This antiandrogen is highly lipophilic and does penetrate preferentially through the hair follicle as has been shown by autoradiography.
D000152:Acne Vulgaris / Q000188:drug therapy; D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D010262:Paraphilic Disorders / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011629:Puberty, Precocious / Q000188:drug therapy*; D012306:Risk; D013329:Structure-Activity Relationship
D000726:Androgen Antagonists